Top Down

1
202006FM 目录
2020, 44(6): 0-0.
2
cover
2021, 45(4): 0-0.
3
《国际放射医学核医学杂志》稿约
2019, 43(1): 98-99. doi: 10.3760/cma.j.issn.1673-4114.2019.01.018
4
contents
2020, 44(2).
5
contents
2020, 44(1): 0-0.
6
cover
2020, 44(12): 0-0.
7
contents
2021, 45(6): 0-0.
8
cover
2020, 44(2).
9
cover
2021, 45(1): -1--1.
10
cover
2021, 45(2): 0-0.
11
cover
2020, 44(8): 0-0.
12
cover
2021, 45(3): 0-0.
13
cover
2020, 44(11): 0-0.
14
cover
2020, 44(4): 0-0.
15
cover
2021, 45(6): -1--1.
16
Current situation and development trend of nuclear medicine in China
Zhixin Zhao, Qiang Wang, Luting Yang, Yong Yang, Haihua Wang, Liyan Jing, Ling Jiao
2020, 44(2): 92-98. doi: 10.3760/cma.j.issn.1673-4114.2020.02.004
17
The influence of nuclear waste water into the sea and suggested measures in Fukushima, Japan
Kaijun Su, Wenqing Xu, Ling Jiao, Jinzhou Du, Saijun Fan
2021, 45(5): 271-275. doi: 10.3760/cma.j.cn121381-202105007-00050
18
Progress in radioligand therapy with 177Lu-PSMA for the treatment of metastatic castration-resistant prostate cancer
Yanhong Zhao, Yue Chen
2019, 43(4): 373-380. doi: 10.3760/cma.j.issn.1673-4114.2019.04.013
19
Prognostic value of 18F-FDG PET/CT metabolic parameters in patients with diffuse large B-cell lymphoma of stage Ⅱ~Ⅲ disease
Chongyang Ding, Lei Ding, Tiannyu Li, Wei Liu, Lijun Tang
2019, 43(3): 203-209. doi: 10.3760/cma.j.issn.1673-4114.2019.03.002
20
Advances of molecular imaging of immune checkpoint targeting PD-1/PD-L1 in tumors
Yan Xing, Jinhua Zhao
2019, 43(4): 356-360. doi: 10.3760/cma.j.issn.1673-4114.2019.04.010
  • First
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Last
  • Total:5
  • To
  • Go